Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C S Lebsack

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Postgraduate Medicine|May 1, 1982
"Purple toes" syndromeC S Lebsack, R T Weibert
Circulation|September 1, 1983
Clinical pharmacology of propafenoneS J Connolly, R E Kates, C S Lebsack, et al.
American Heart Journal|August 1, 1986
Ethmozine: electrophysiology, hemodynamics, and antiarrhythmic efficacy in patients with life-threatening ventricular arrhythmiasP Dorian, D S Echt, R H Mead, et al.
The American Journal of Cardiology|December 1, 1983
Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardiaS J Connolly, R E Kates, C S Lebsack, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Postgraduate Medicine|May 1, 1982
"Purple toes" syndromeC S Lebsack, R T Weibert
Circulation|September 1, 1983
Clinical pharmacology of propafenoneS J Connolly, R E Kates, C S Lebsack, et al.
American Heart Journal|August 1, 1986
Ethmozine: electrophysiology, hemodynamics, and antiarrhythmic efficacy in patients with life-threatening ventricular arrhythmiasP Dorian, D S Echt, R H Mead, et al.
The American Journal of Cardiology|December 1, 1983
Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardiaS J Connolly, R E Kates, C S Lebsack, et al.
Pageof 1